Mediwound Ltd (MDWD)

Mediwound Ltd (MDWD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $158M; returns 1 day -1.5%, 1 week +1.3%, 1 year -35.1%.

MediWound Ltd. (Nasdaq: MDWD) is an Israel-based global biotechnology company focused on developing and commercializing next-generation enzymatic therapies for non-surgical tissue repair. The company's primary revenue driver is NexoBrid, an FDA-approved biologic for the enzymatic removal of eschar in deep partial- and full-thickness thermal burns.

Groups MDWD belongs to

• Biotechnology
• Israel Companies
• Healthcare
• Biopharmaceutical
• Israel
• Biologics
• Commercial Stage Biotech
• Clinical Stage Biotech
• Public Safety and Security
• National Security

MDWD financial model: income statement, cash flow and balance sheet